pop up description layer
Hledání v detailu akcií
Top akcie
NázevNávštěvy
31 888
5 436
5 430
3 105
1 905
1 831
1 643
1 190
1 141
1 117
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ552,40553,501,28
KB3 866,003 870,000,94
PKN51,3751,401,00
Richter35 600,0035 675,002,09
Msft33,8434,54-1,33
IBM206,34206,50-0,40
DCX47,8247,85-0,47
PFE29,1129,12-0,65
24.5.2013 10:54:00
Indexy online
AD Index online
AD Index online
Výsledková sezóna 1Q
Výsledky společností
USA  datum EPSe EPS 
Alcoa 8.4. 0,080 0,11
Wells Fargo 12.4. 0,884 0,92
JPMorgan 12.4. 1,393 1,59
Citigroup15.4. 1,195 1,23
Goldman Sachs 16.4.  3,826 4,29
Coca-Cola Co 16.4. 0,446 0,46
Intel 16.4. 0,404 0,40
Bank of America 17.4. 0,226 0,20
Microsoft 18.4. 0,733 0,72
Yahoo!18.4.0,2500,35
Google 18.4. 10,64 11,6
IBM 18.4.  3,062 3,00
Morgan Stanley18.4.0,5600,61 
Philip Morris Int18.4. 1,3401,29
General Electric 19.4.  0,347  0,35 
McDonald's19.4.1,2651,26
Caterpillar22.4. 1,381,31 
Apple 23.4.  9,98 10,09
Ford24.4. 0,370,41
Boeing24.4. 1,4881,73
Exxon Mobil25.4. 2,04 2,12 
Altria25.4. 0,5280,54 
3M25.4. 1,65 1,61 
Amazon26.4. 0,10 0,18 
Chevron26.4. 3,064 3,18
Volkswagen29.4. 4,1754,18
Pfizer 30.4. 0,547 0,54
Deutsche Bank30.4. 1,3771,79 
Facebook 1.5. 0,125 0,12 
General Motors2.5. 0,550 0,67 
AIG3.5. 0,880 1,34
Walt Disney 7.5. 0,77 0,79 
Cisco 15.5. 0,492 0,51 
Dell17.5.0,346 0,21
Hewlett-Packard22.5. 0,81 0,87 
EPS(e) = zisk/akcie (odhad/realita)
 




 

  • 24.5.2013 10:43:21
Ipsen (IPN.PA, Paris)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
26,34 -0,25 -0,07 34 802
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
Popis společnosti
Obecné informace
Název společnostiIpsen SA
TickerIPN
ISINFR0010259150
RICIPN.PA
Poslední známé roční výsledky 
Poslední známé čtvrtletní výsledky 
Počet zaměstnanců 
Počet vydaných akcií 
MěnaEUR
Kontaktní informace
Ulice65, quai Georges Gorse
MěstoBOULOGNE-BILLANCOURT
PSČ92100
ZeměFrance
Kontatní osobaPierre Kemula
Funkce kontaktní osobyInvestor Relations Officer
Telefon33158335000
Fax33158335001
Kontatní telefon3315835000

Business Summary: Ipsen SA is a France-based pharmaceutical company that produces a range of various types of drugs. Its portfolio includes pharmaceutical products divided into four targeted therapeutic areas: Neurology, Endocrinology, Uro-Oncology and Primary Care. In the Neurology segment the Company offers a product called Dysport, in Endocrinology field Ipsen produces Somatuline, Somatuline-Autogel, NutropinAq, Increlex; the Uro-Oncology field proposes Decapeptyl and Hexvix; Primary Care field offers Nisis-Nisisco, Forlax-Fortrans, Tanakan and Smecta. The Group also sells products in other therapeutic areas in which it boasts longstanding expertise (gastroenterology, cardiovascular and cognitive disorders).
Financial Summary: BRIEF: For the fiscal year ended 31 December 2012, Ipsen SA revenues increased 6% to EUR1.28B. Net income before extraordinary items increased 30% to EUR95.3M. Revenues reflect Endocrinology segment increase of 16% to EUR307.6M, Oncology segment increase of 12% to EUR318.7M, Neuromuscular Disorders segment increase of 12% to EUR236.2M, Asia segment increase of 21% to EUR167.3M, Other European Countries segment increase of 9% to EUR306M.
Odvětvová klasifikace
TRBC2009Pharmaceuticals - Diversified
TRBC2012Pharmaceuticals - NEC
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences
SICPharmaceutical Preparations
SICBiological Prod's Not Diagnostic
SICCommercial Physical Research



Management společnosti
FunkceJménoVe funkci od
Chairman of the Board and Chief Executive Officer, Member of the Executive CommitteeMarc de Garidel22.11.2010
Member of the Executive Committee, Deputy Chief Executive OfficerChristel Bories1.3.2013
Vice Chairman of the Board of Directors and DirectorAntoine Flochel30.8.2005
Executive Vice President - Finance, Member of the Executive CommitteeSusheel Surpal1.12.2011
Executive Vice President - Operations, Member of the Executive CommitteeChristophe Jean
Member of the Executive Committee, Executive Vice President - Research & Development, Chief Scientific OfficerClaude Bertrand2.11.2009
Executive Vice President - Legal Affairs, Member of the Executive CommitteeNathalie Joannes1.10.2011
Executive Vice President - Human Resources, Member of the Executive CommitteeEtienne de Blois11.5.2011
Executive Vice President - Corporate Strategy, Member of the Executive CommitteePierre Boulud1.1.2002
Executive Vice President - Technical Operations, Member of the Executive CommitteeEric Drape2.5.2007